Marketing-authorisation holder · United States
Lupin
76 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
76 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 76
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMABELZ0.5mg; 0.1mg | 1mg; 0.5mg · Tablet | Estradiol, Norethindrone | United States | Marketed | 2016 |
| ANTARA (MICRONIZED)130MG | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 43MG | 87MG | 90MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Fenofibrate | United States | Marketed | 2004 |
| ARMLUPEG6mg/0.6ml · Injection | Pegfilgrastim | United States | Marketed | 2025 |
| AZILSARTAN MEDOXOMIL40mg medoxomil | 80mg medoxomil · Tablet | Azilsartan kamedoxomil | United States | Marketed | 2022 |
| BEKYREE0.15mg,n/a; 0.02mg,0.01mg · Tablet | Desogestrel, N/a, Ethinyl estradiol | United States | Marketed | 2015 |
| BLISOVI 24 FE0.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2015 |
| BLISOVI FE 1/200.02mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2015 |
| BLISOVI FE 1.5/300.03mg; 1.5mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Marketed | 2015 |
| BREXPIPRAZOLE0.25mg | 0.5mg | 1mg | 2mg | 3mg | 4mg · Tablet | Brexpiprazole | United States | Marketed | 2021 |
| BRIVARACETAM100mg | 100MG | 10MG | 25mg | 25MG | 50mg | 50MG | 75mg | 75MG · Tablet | Brivaracetam | United States | Marketed | 2022 |
| BROVANA0.015mg base/2ml · Solution | Arformoterol | United States | Not marketed | 2006 |
| CEFDINIR300mg · Capsule | Cefdinir | United States | Marketed | 2006 |
| CEFDINIR125mg/5ml | 250mg/5ml · For suspension | Cefdinir | United States | Marketed | 2006 |
| CLOBAZAM10mg | 20mg | 5mg · Tablet | Clobazam | United States | Marketed | 2018 |
| DAYSEE0.03mg,0.01mg; 0.15mg,n/a · Tablet | Ethinyl estradiol, Levonorgestrel, N/a | United States | Marketed | 2013 |
| DOXYCYCLINE25mg base/5ml · For suspension | Doxycycline | United States | Marketed | 2008 |
| DROSPIRENONE AND ETHINYL ESTRADIOL3mg; 0.03mg · Tablet | Drospirenone, Ethinyl estradiol | United States | Marketed | 2008 |
| DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM3mg,n/a; 0.02mg,n/a; 0.451mg,0.451mg | 3mg,n/a; 0.03mg,n/a; 0.451mg,0.451mg · Tablet | Drospirenone, N/a, Ethinyl estradiol, Levomefolate | United States | Marketed | 2016 |
| EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE120mg; 15mg base | 200mg; 25mg base · Tablet | Emtricitabine, Tenofovir alafenamide | United States | Marketed | 2024 |
| ENSKYCE0.15mg; 0.03mg · Tablet | Desogestrel, Ethinyl estradiol | United States | Marketed | 2013 |
| ESLICARBAZEPINE ACETATE200mg | 400mg | 600mg | 800mg · Tablet | Eslicarbazepine | United States | Marketed | 2021 |
| FALLBACK SOLO1.5mg · Tablet | Levonorgestrel | United States | Marketed | 2014 |
| FAYOSIM0.02mg,0.15mg; 0.025mg,0.15mg · Tablet | Ethinyl estradiol, Levonorgestrel | United States | Not marketed | 2016 |
| FORMOTEROL FUMARATE0.02mg/2ml · Solution | Formoterol | United States | Marketed | 2021 |
| FOSAMPRENAVIR CALCIUM700mg | 700mg base · Tablet | Fosamprenavir | United States | Marketed | 2016 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 76 | 61 | 15 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.